Andra CA, Rambe AS, Hasan R, Sembiring R, Firman D, Eyanoer PC, et al. Proprotein convertase subtilisin/kexin type 9 (PCSK9) as a marker of coronary lesion severity in stable coronary artery disease (CAD) patients . Narra J [Internet]. 2023 Dec. 29 [cited 2026 Apr. 11];3(3):e409. Available from: https://www.narraj.org/main/article/view/409